Literature DB >> 24823521

Cardiovascular abnormalities with single dose of tapentadol.

A Vachhani, M Barvaliya, V Naik, C B Tripathi1.   

Abstract

This case represents the development of dizziness, palpitation, tightness in chest, flushing, and tremor on consumption of a single dose of tapentadol (100 mg) for acute lower back pain. The patient was admitted in the intensive cardiac care unit for continuous monitoring. At admission, electrocardiogram showed tachycardia (140/min) along with ST segment elevation in second chest lead (V2). The patient was monitored and advised not to take further doses of tapentadol. He was discharged after 36 hours of admission. Tapentadol should be used cautiously in patients with cardiovascular diseases and receiving sympathomimetic drugs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24823521     DOI: 10.4103/0022-3859.132341

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  3 in total

Review 1.  Spinal α2 -adrenoceptors and neuropathic pain modulation; therapeutic target.

Authors:  Zahra Bahari; Gholam Hossein Meftahi
Journal:  Br J Pharmacol       Date:  2019-03-06       Impact factor: 8.739

2.  Role of preemptive tapentadol in reduction of postoperative analgesic requirements after laparoscopic cholecystectomy.

Authors:  Ghanshyam Yadav; Gaurav Jain; Abhishek Samprathi; Annavi Baghel; Dinesh Kumar Singh
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2016 Oct-Dec

Review 3.  Cardiac Arrest Following Drug Abuse with Intravenous Tapentadol: Case Report and Literature Review.

Authors:  Misbahuddin Khaja; George Lominadze; Konstantin Millerman
Journal:  Am J Case Rep       Date:  2017-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.